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Abstract
Background: Organochlorine insecticides (OCs) have historically been used worldwide to control insects, although
most have now been banned in developed countries. Evidence for an association between OC exposures and
cancer predominantly comes from occupational and population based-studies among men. We evaluated the
association between the use of specific OCs and cancer among the female spouses of pesticide applicators in the
Agricultural Health Study.
Methods: At enrollment (1993–1997), spouses of private applicators in the cohort provided information about their
own use of pesticides, including seven OCs (aldrin, chlordane, dieldrin, DDT, heptachlor, lindane, and toxaphene),
and information on potential confounders. We used Poisson regression to estimate relative risks (RRs) and 95%
confidence intervals (CIs) for cancers (n ≥ 3 exposed cases) reported to state cancer registries from enrollment
through 2012 (North Carolina) and 2013 (Iowa), and use of the individual OCs, as well as use of any of the
specific OCs.
Results: Among 28,909 female spouses, 2191 (7.58%) reported ever use of at least one OC, of whom 287 were
diagnosed with cancer. Most cancers were not associated with OC use. Risk of glioma was increased among users
of at least one OC (Nexposed = 11, RR = 3.52, 95% CI 1.72–7.21) and specifically among lindane users (Nexposed = 3,
RR = 4.45, 95% CI 1.36–14.55). Multiple myeloma was associated with chlordane (Nexposed = 6, RR = 2.71, 95% CI
1.12–6.55). Based on 3 exposed cases each, there were also positive associations between pancreatic cancer and
lindane, and ER-PR- breast cancer and dieldrin. No other associations with breast cancer were found.
Conclusions: Overall, there were some associations with OC use and cancer incidence, however we were limited
by the small number of exposed cancer cases. Future research should attempt to expand on these findings by
assessing environmental sources of OC exposures, to fully evaluate the role of OC exposures on cancer risk
in women.
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Background
Organochlorine insecticides (OCs) are a class of
chlorinated hydrocarbon insecticides historically used
worldwide in agriculture. Some are still used in some
developing countries for the control of vector borne ill-
nesses [1–3]. OCs were first introduced in the United
States in the 1940s and were used widely in agriculture
and pest control through the 1960s. Due to their envir-
onmental persistence and ability to bioacccumulate,
most OCs were banned for use in the U.S. during the
1970s and 1980s. Lindane and endosulfan were banned
more recently in 2006 and 2010, respectively [4–6]. The
International Agency for Research on Cancer (IARC)
has reviewed the carcinogenicity of fifteen OCs. Of
these, lindane [7] and pentachlorophenol (PCP) [8]
were classified as Group 1, carcinogenic to humans; di-
chlorodiphenyltrichloroethane (DDT) [7], aldrin [8]
and dieldrin [8] as Group 2A, probably carcinogenic to
humans; 2,4,6-trichlorophenol (TCP) [8], chlordane [9],
chlordecone [10], heptachlor [9], hexachlorocylcohex-
anes (HCH) [10], hexachlorobenzene (HCB) [9], mirex
[10], and toxaphene [9] as Group 2B, possibly carcino-
genic to humans; and endrin [10] and methoxychlor
[10] classified as Group 3, not classifiable as to their
carcinogenicity to humans.
The strongest epidemiologic evidence for a link
between OC exposures and cancer risk comes from oc-
cupational and population-based studies of non-
Hodgkin lymphoma (NHL) [11–19]. Previous analyses of
licensed pesticide applicators in the Agricultural Health
Study (AHS) found significant positive exposure-response
trends for lindane and DDT use with NHL [12], and
chlordane and heptachlor use with leukemia [20]. In a
pooled analysis of Canadian and U.S. based case–control
studies, self-reported ever use of DDT was significantly as-
sociated with multiple myeloma (MM) [17]. The strongest
evidence for associations with cancer at other sites
comes from case–control studies of liver and testicular
cancers [21–24]. DDT, dichlorodiphenyldichloroethy-
lene (ρ, ρ’ -DDE), and β-HCH have been associated
with hepatocellular carcinoma [21–23], and testicular
germ cell tumors have been significantly associated with
prediagnostic serum DDE and chlordane metabolites [24].
There is also evidence for significant positive associations
with OC exposures and cancers of the prostate [25], skin
(cutaneous melanoma) [20], lung [20], rectum [20], and
pancreas [26, 27]. An evaluation of pesticides and gli-
oma reported no association with OCs [28].
In addition, potential associations between OCs and
hormonally-mediated cancers, particularly female breast
cancer, are of concern due to the endocrine disrupting
properties of OCs [29–38]. While two studies [34, 35]
have suggested an association with dieldrin, most studies
are null [29, 32, 33, 36–39]. However, several reports
provide evidence for an increased risk of breast cancer
in adulthood with early life exposure to OCs [40–43].
The one study of endometrial cancer found no associa-
tions with OCs overall [44]. No studies to our know-
ledge have investigated associations with ovarian cancer.
Although in vitro and in vivo studies suggest OCs may
act as estrogen agonists or antagonists [45–48], the rela-
tionship between OCs and hormonally-mediated cancers
among women remains unclear. In this paper, we
examine the associations between multiple site-specific
cancers and self-reported personal use of OCs among
the female spouses of AHS applicators.
Methods
Study population and follow-up
The AHS is a prospective cohort that includes licensed
private pesticide applicators (mostly farmers), and the
spouses of private pesticide applicators residing in Iowa
and North Carolina. The AHS has been previously
described in detail [49]. Pesticide applicators were re-
cruited from 1993 to 1997 when obtaining a license to
apply restricted-use pesticides. Private pesticide applica-
tors who reported being married at the time of enroll-
ment were given questionnaires to be completed by
their spouses. The spouses (n = 32,345) of these private
pesticide applicators are the focus of this study. The
Spouse Enrollment questionnaire elicited information
on demographic and lifestyle factors, family and per-
sonal medical histories, farm exposures, and agricul-
tural activities, including the application or mixing of
specific pesticides. In addition, 60.0% of the spouses in
this analysis also completed the Female and Family
Health questionnaire which focused on reproductive
health histories. The study protocol was approved by all
relevant institutional review boards. Study question-
naires are publicly available (https://aghealth.nih.gov/
collaboration/questionnaires.html).
Cancer incidence was assessed regularly via linkage
with the North Carolina and Iowa state cancer registries.
Mortality incidence was assessed through regular linkage
with state mortality registries and The National Death
Index. Cancer sites were classified according to the
International Classification of Diseases for Oncology, 3rd
revision (World Health Organization). For NHL, we
followed the Surveillance Epidemiology and End Results
(SEER) lymphoma coding scheme [50].
Exposure assessment and questionnaires
Spouses of private pesticide applicators were enrolled in
the AHS from 1993 to 1997, during which time they
reported their lifetime never/ever personal use of fifty
pesticides including past use of seven OCs (aldrin, chlor-
dane, dieldrin, DDT, heptachlor, lindane and toxaphene).
For each pesticide, they were asked ‘During your
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lifetime, have you ever personally mixed or applied
[pesticide]? (Includes pesticides used for farm use, com-
mercial application and personal use in your home or
garden)’. Participants who indicated ever use of at least
one of these seven OCs were classified as having person-
ally used ‘any OC’, whereas those who indicated never
use of any of these OCs were classified as never having
personally used ‘any OC’. Otherwise, participants were
considered to be missing as to their ‘any OC’ use. In the
following analysis, the term ‘any OC’ will be used to
refer to the ever personal use of at least one of these
seven OCs.
Statistical analysis
For this analysis we excluded, the 219 male spouses,
women who were diagnosed with cancer prior to study
enrollment (n = 905), those with zero or missing person
years of follow-up (n = 161), and those missing informa-
tion on use for all seven OCs (n = 2146), leaving 28,909
female spouses in our analytic cohort. Relative risks (RR)
and 95% confidence intervals (95% CI) were calculated
for risk of cancer among ever users, compared to never
users, using multivariable Poisson regression in SAS ver-
sion 9.3 (SAS Institute, Inc., Cary, N.C.). We evaluated
all cancer sites with at least three exposed cases for asso-
ciations with each of the seven individual OCs and for
the use of any OC as defined previously. Person-time ac-
crued from the date of study enrollment until date of
death, cancer diagnosis, movement out of state or last
study-follow-up (December 31, 2012 and December 31,
2013 for North Carolina and Iowa respectively), which-
ever was earliest. For the evaluation of uterine and
ovarian cancers, person-time was censored at the time
of hysterectomy or oophorectomy, where applicable.
All models were adjusted for age at enrollment
(≤44 years, 45–54 years, 55–64 years, ≥ 65 years), educa-
tional attainment (high school degree or less, some col-
lege or college graduate, one or more years of graduate
school), alcohol use (never, less than 1 drink per month,
≥ 1–3 per month), cigarette pack-years smoked as re-
ported at enrollment (pack-year quartiles: Never, ≤ 6.75,
6.751–16.75, ≥ 16.751), and state of residence (Iowa or
North Carolina). We considered the following additional
confounders: BMI, race, family history of cancer, and
ever use of any pesticide, but did not include them in
our final models as they did not appreciably alter our re-
sults by ≥ 10%. For all cancer sites, mutually adjusting
for individual non-OC and OC pesticides that were cor-
related at ρ ≥ 0.4 (i.e. aldrin and dieldrin (ρ = 0.43), aldrin
and heptachlor (ρ = 0.42)) did not appreciably change
our results and these adjustments were not included in
our final models. Moreover, because dieldrin is also a
biological metabolite of aldrin, we performed sensitivity
analyses where ‘dieldrin metabolite’ (i.e. those farm
spouses who personally used either aldrin or dieldrin)
was modeled as the exposure. However, these analyses
did not significantly alter our existing aldrin and dieldrin
results, and were not included in our final analyses.
Additionally, we examined potential confounders
known to be associated with specific cancer sites, such
as total meat consumption (colon, rectum, stomach),
sun sensitivity (melanoma), asbestos exposure (lung),
autoimmune disorders, exposure to livestock and
poultry, and benzene exposure (lymphohematopoeitic
cancers); adjusting for these specific cancer-related co-
variates did not alter our results and were not included
in our final models. All OC-exposed brain cancer cases
were glioma subtypes; thus, we report associations here
for glioma only. Breast cancers were examined overall,
as well as by estrogen receptor (ER) and progesterone
receptor (PR) status, where available. Female health and
reproductive covariates at enrollment were also exam-
ined, with respect to breast, ovarian and uterine cancer,
and included the following: menopausal status, ever use
of oral contraceptives, ever use of estrogen-based hor-
mone replacement therapy, ever use of progestin based
hormone replacement therapy, age at menarche, and
parity. These female reproductive covariates did not ap-
pear to significantly alter our results and thus were not
included in our final models. Due to a lack of question-
naire information availability, we were unable to assess
age at first live birth as a potential covariate. We con-
ducted stratified analyses by several female health co-
variates, including menopausal status at enrollment
(yes/no), ever use of oral contraceptives at enrollment
(yes/no), ever use of hormone replacement therapy at
enrollment (yes/no) and age at first menarche (≤ 12 years
or below, > 12 years). Due to the small number of nul-
liparous women (n = 294), we were unable to evaluate
risks among nulliparous women.
Results
From enrollment through 2012/2013, the 28,909 female
spouses contributed a total of 502,895 person-years of
follow-up (Mean = 16.19 standard deviation +/− 3.8).
Overall, 15,112 (52.3%) reported ever using any pesticide
(data not shown), and 2191 (7.6%) reported ever use of
any of the seven OCs included in the enrollment ques-
tionnaire. The most commonly reported OCs were
chlordane (4.1%), DDT (3.55%) and lindane (1.5%), with
less than 1% of participants reporting ever use of aldrin,
heptachlor, toxaphene and dieldrin (Table 1). Among
women who reported using any OC, 718 (32.8%) re-
ported use of more than one OC. Ever OC users tended
to be older, have higher BMIs, be from Iowa, and have a
higher educational level than OC non-users. They were
also more likely to have reported a family history of can-
cer, grown up on a farm, used oral contraceptives, and
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Table 1 Select characteristics of AHS farm spouses at enrollment with OC insecticide personal use information (n = 28,909)a
Any OC useb
Never Ever
N = 26,718 % N = 2,191 % p value±
Age at enrollment
≤ 44 13,153 49.23 447 20.40 < .0001
45–54 6,677 24.99 771 35.19
55–64 4,823 18.05 731 33.36
≥ 65 2,065 7.73 242 11.05
Race
White 26,164 97.93 2,178 99.4 < .0001
Other 510 1.91 8 0.37
Missing 44 0.16 5 0.23
State of Residence
North Carolina 8,739 32.71 632 28.85 0.0002
Iowa 17,979 67.29 1,559 71.15
Educational Attainment
High School or less 13,905 52.04 1,102 50.3 0.0015
Some College or College Graduate 8,662 32.42 679 30.99
1 or more years of Graduate School 3,833 14.35 378 17.25
Missing 318 1.19 32 1.46
Body Mass Index
0–24.99 11,756 40.67 902 41.17 < .0001
25.00–29.99 7,448 25.76 717 32.72
≥ 30.00 4,298 14.87 440 20.08
Missing 3,216 11.12 132 6.02
Alcohol
Never 12,042 45.07 939 42.86 0.2371
Less than once/month 7,099 26.57 603 27.52
≥ 1–3 times per month 7,277 27.24 621 28.34
Missing 300 1.12 28 1.28
Cigarette Smoking (Pack-years)
Never Smoker 18,820 70.44 1,493 68.14 0.0003
≤ 6.75 3,544 13.26 294 13.42
6.751–16.75 1,752 6.56 127 5.80
≥ 16.751 1,700 6.36 186 8.49
Missing 902 3.38 91 4.15
Family History of Cancer
No/Missing 13,949 52.21 949 43.31 < .0001
Yes 12,769 47.79 1,242 56.69
Grew up on a farm
No 10,913 40.85 534 24.37 < .0001
Yes 15,579 58.30 1,643 74.99
Missingc 226 0.85 14 0.64
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have an earlier onset of menarche. Additionally, 77.5% of
OC users completed the Female and Family Health
Questionnaire versus 60.5% of never OC users.
Any OC use was significantly associated with an in-
creased risk of glioma (Nexposed = 11; RR = 3.52, 95% CI
1.72 to 7.21) (Table 2). Lindane use was significantly as-
sociated with an increased risk of glioma (Nexposed = 3,
RR = 4.45 95% CI 1.36 to 14.55) and pancreatic cancer
(Nexposed = 3, RR = 3.70 95% CI 1.15 to 12.0). Use of any
OC was also associated with non-significantly elevated
risks of stomach cancer (Nexposed = 5, RR = 2.61, 95% CI
0.96 to 7.11), and colon cancer (Nexposed = 28, RR = 1.19,
95% CI 0.80 to 1.75).
Although chlordane use (Nexposed = 6, RR = 2.71, 95%
CI 1.12 to 6.55) was significantly associated with an in-
creased risk for MM, any OC use (Nexposed = 8, RR = 2.01,
95% CI 0.91 to 4.42) and DDT use (Nexposed = 4,
RR = 1.75, 95% CI 0.61 to 5.01) were non-significantly
associated with an increased risk of MM (Table 2).
There were also several suggestive associations for lym-
phoematopoietic malignancies. Any OC use was non-
significantly associated with an increased risk for NHL
overall (Nexposed = 28, RR = 1.23, 95% CI 0.82 to 1.83).
Similarly, use of chlordane (Nexposed = 17, RR = 1.30,
95% CI 0.82 to 2.22), DDT (Nexposed = 17, RR = 1.35,
95% CI 0.81 to 2.22), and lindane (Nexposed = 6, RR = 1.60,
Table 1 Select characteristics of AHS farm spouses at enrollment with OC insecticide personal use information (n = 28,909)a
(Continued)
Menopause at Enrollment
No 8,922 33.39 534 24.37 < .0001
Yes 6,777 25.36 1,127 51.44
Unsure 245 0.92 22 1.00
Missingc 10,774 40.32 508 23.19
Number of Live Births
0 235 0.88 29 1.32 < .0001
1 or 2 7,216 27.01 688 31.40
> 2 7,526 28.17 887 40.48
Missingc 11,741 43.94 587 26.79
Oral Contraceptive Use
Never 4,236 15.85 576 26.29 < .0001
Ever 11,722 43.87 1,106 50.48
Missingc 10,760 40.27 509 23.23
Age of first menarche
12 years or less 7,099 26.57 788 35.97 < .0001
13 years 4,851 18.16 493 22.5
14 years or greater 3,855 14.43 398 18.17
Missingc 10,913 40.85 512 23.37
OC Insecticides
Overall OC (Any OC) - - 2,191 7.58 -
Chlordane - - 1,196 4.13 -
DDT - - 1,028 3.55 -
Lindane - - 430 1.47 -
Aldrin - - 235 0.81 -
Hepatchlor - - 222 0.77 -
Toxaphene - - 203 0.70 -
Dieldrin - - 105 0.36 -
AHS Agricultural Health Study, RR relative risks, OC organochlorines
±Chi Square test for homogeneity
aExcluded: n = 2146 with missing information for personal use of all OCs; n = 905 female spouses diagnosed with cancer prior to enrollment; n = 219 male
spouses; n = 161 with missing or 0 person-years of follow-up leaving a total n = 28,909 female farm spouses
bEver use of any of the seven OC insecticides
cFrom Female & Family Health Questionnaire responses
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95% CI 0.71 to 3.60) were also non-significantly asso-
ciated with increased risks in NHL. We had limited
power for NHL subtype analyses. However, all 28 OC
exposed cases were B-cell lymphomas. Among women
who reported any OC use, there were eight MM
cases and six diffuse large B-cell lymphoma (DLBCL);
no other B-cell subtype had more than four exposed
cases.
We also evaluated hormone-mediated cancers in-
cluding ovarian, uterine, and breast (see Table 2). No
significant associations were found for any OC use or
for use of the seven individual OCs and uterine or
ovarian cancers. Similarly, we found no association
between any OC use or for use of the seven individual
OCs and breast cancer. In analyses of breast cancer sub-
type, there was a statistically significant elevated associ-
ation between dieldrin use and ER-PR- breast cancer
(Nexposed = 3, RR = 3.55, 95% CI 1.12 to 11.18).
Discussion
In this study, we prospectively evaluated associations be-
tween the reported personal use of individual OCs and
incident cancers in a population of female farm spouses.
Although the numbers of exposed cases were small, we
observed statistically significant increased risks for use
of individual OCs insecticides and several cancers, in-
cluding any OC use and glioma, lindane use and glioma
and pancreatic cancer, chlordane use and MM, and diel-
drin use and ER−/PR- breast cancer.
In addition to chlordane, MM was non-significantly
associated with any OC use and with DDT specifically.
These associations are consistent with previous findings
[11–14, 17, 18]. The definition of NHL used in our study
is based on the most recent lymphoma classification
system, which includes MM as a subtype of NHL [50],
whereas most previous studies relied on earlier classifi-
cations which considered MM separately. A previous
Table 2 RR and CIsb for ever versus never use of OC insecticides, for all cancer sites±
N total Any OC
a Chlordane DDT Lindane
N exposed RR 95% CI N exposed RR 95% CI N exposed RR 95% CI N exposed RR 95% CI
All Cancer Sitesc 3,204 287 0.96 0.85–1.08 160 0.99 0.84–1.16 158 0.98 0.83–1.15 46 0.91 0.68–1.22
Solid tumors
Bladder 103 4 0.64 0.23–1.77 1 _ _ 3 0.83 0.26–2.67 1 _ _
Colon 236 28 1.19 0.80–1.75 18 1.42 0.87–2.32 16 1.17 0.70–1.95 3 0.79 0.25–2.49
Glioma 44 11 3.52 1.72–7.21 4 1.81 0.64–5.12 2 _ _ 3 4.45 1.36–14.55
Kidney 71 6 0.89 0.38–2.08 3 0.85 0.26–2.72 5 1.41 0.56–3.57 0 _ _
Lung 203 15 0.70 0.41–1.20 10 0.90 0.47–1.71 10 0.84 0.44–1.59 2 _ _
Melanoma (cutaneous) 145 12 1.08 0.59–1.97 4 0.63 0.23–1.72 5 0.88 0.36–2.18 2 _ _
Pancreas 55 7 1.33 0.59–2.97 3 1.03 0.32–3.34 1 _ _ 3 3.70 1.15–12.0
Rectum 69 8 1.27 0.60–2.70 6 1.80 0.77–4.21 6 1.79 0.76–4.22 0 _ _
Stomach 26 5 2.61 0.96–7.11 1 _ _ 3 2.64 0.76–9.15 1 _ _
Thyroid 54 5 0.66 0.26–1.63 4 0.97 0.36–2.67 1 _ _ 0 _ _
Lymphohematopoietic malignancies
NHL 233 28 1.23 0.82–1.83 17 1.35 0.82–2.22 17 1.35 0.81–2.22 6 1.60 0.71–3.60
Multiple Myeloma 42 8 2.01 0.91–4.42 6 2.71 1.12–6.55 4 1.75 0.61–5.01 1 _ _
Myeloid Leukemia 34 4 1.26 0.44–3.65 3 1.82 0.55–6.09 3 1.66 0.49–5.56 0 _ _
Female specific sites
Breast 1,214 99 0.89 0.72–1.09 56 0.93 0.71–1.22 52 0.89 0.67–1.18 17 0.88 0.54–1.42
ER + PR+ 736 64 0.94 0.73–1.23 36 0.98 0.70–1.37 33 0.93 0.65–1.33 9 0.75 0.39–1.45
ER-PR- 202 15 0.82 0.48–1.40 9 0.90 0.46–1.76 7 0.76 0.36–1.63 4 1.22 0.45–3.30
ER + PR- 125 8 0.65 0.32–1.35 5 0.78 0.32–1.92 4 0.61 0.22–1.67 2 _ _
Ovarian 106 9 0.65 0.30–1.61 7 1.05 0.40–2.89 5 0.77 0.20–2.46 2 _ _
Uterine 276 20 0.83 0.50–1.32 10 0.80 0.40–1.50 10 0.82 0.42–1.56 2 _ _
Significant Findings are listed in boldface
AHS Agricultural Health Study, RR relative risks, OC organochlorines, ER estrogen receptor, PR progesterone receptor
±n ≥ 3 exposed cases
aEver use of any of the seven OC insecticides
bAdjusted for age, education, state of residence, pack-years smoked, and alcohol consumption
cInclusive of all reported cancer sites
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population-based case–control study found non-significant
positive associations of ever handling (mixing or applying)
aldrin, DDT, or lindane with MM [51]. A pooled analysis
of U.S. and Canadian case-controls studies found that
DDT use was significantly associated with MM [17]; cu-
mulative exposure to DDT, as measured by lifetime-days of
use, was also significantly associated with an increasing risk
trend for MM. Although not significant, in the current
study, chlordane use was also positively associated with
NHL and myeloid leukemia, DDT use was positively asso-
ciated with NHL and myeloid leukemia, and lindane use
was positively associated with NHL. There is evidence that
some OCs, including lindane and DDT, cause oxidative
stress and immunosuppressive effects, and that these
mechanisms possibly play a role in the development of
lymphohematopoietic cancers [7, 52–55].
We observed no significant association with Any OC
use and breast cancer overall. Although some studies
have reported an increased risk of breast cancer among
women exposed to OCs during critical developmental
windows in early life [41–43], our findings are consistent
with most other studies that also did not evaluate timing
of exposure [7, 29, 30, 32–39]. Although we did not have
information on timing of exposure, we conducted
sensitivity analyses using year of birth as a surrogate for
the potential for exposure during critical developmental
periods. OCs were first registered in 1948, therefore we
assumed women born before 1936 would not have any
OC exposures prior to menarche. When we restricted
analyses to women born after 1936, the RR for breast
cancer and any OC use was 1.22 (0.94–1.59) (n = 61 ex-
posed cases) compared to 0.84 (0.60–1.18) (n = 38 ex-
posed cases) among women who were born prior to
1936. Although there was some evidence to indicate po-
tential differences between the two groups, the test for
interaction was not statistically significant (p = 0.11. An
early study by Wolff et al. found a two- to four-fold in-
creased risk of breast cancer among women with the
highest serum DDE levels, with a positive trend with in-
creasing serum DDE [30]. However, a follow-up study
with a larger sample size found no evidence for an asso-
ciation of breast cancer risk with serum DDE levels [56].
Additional studies of breast cancer and OC exposures
have examined associations with mirex, HCB, and chlor-
dane; most of these studies also reflected null or incon-
clusive findings [33, 36, 57–59].
We did, however, see an association between dieldrin
use and ER−/PR- breast cancer based on only 3 exposed
Table 2 RR and CIsb for ever versus never use of OC insecticides, for all cancer sites± (Continued)
N total Aldrin Heptachlor Toxaphene Dieldrin
RR 95% CI N exposed RR 95% CI N exposed RR 95% CI N exposed RR 95% CI
All Cancer Sitesc 3,204 1.12 0.82–1.53 36 1.06 0.76–1.48 29 1.05 0.73–1.52 17 1.02 0.63–1.65
Solid tumors
Bladder 103 _ _ 0 _ _ 1 _ _ 0 _ _
Colon 236 1.73 0.76–3.91 4 1.24 0.46–3.36 3 1.31 0.42–4.12 4 2.41 0.89–6.53
Glioma 44 _ _ 2 _ _ 2 _ _ 0 _ _
Kidney 71 _ _ 0 _ _ 2 _ _ 0 _ _
Lung 203 _ _ 1 _ _ 5 2.13 0.87–5.21 2 _ _
Melanoma (cutaneous) 145 2.20 0.69–7.02 3 2.40 0.75–7.64 1 _ _ 1 _ _
Pancreas 55 _ _ 1 _ _ 0 _ _ 0 _ _
Rectum 69 _ _ 1 _ _ 1 _ _ 0 _ _
Stomach 26 _ _ 0 _ _ 0 _ _ 0 _ _
Thyroid 54 _ _ 1 _ _ 0 _ _ 0 _ _
Lymphohematopoietic malignancies
NHL 233 _ _ 3 1.03 0.33–3.24 3 1.49 0.48–4.68 0 _ _
Multiple Myeloma 42 _ _ 1 _ _ 1 _ _ 0 _ _
Myeloid Leukemia 34 _ _ 1 _ _ 0 _ _ 0 _ _
Female specific sites
Breast 1,214 0.88 0.48–1.59 11 0.93 0.51–1.68 5 0.49 0.20–1.18 6 1.06 0.48–2.38
ER + PR+ 736 1.00 0.50–2.02 8 1.05 0.52–2.11 2 _ _ 3 0.83 0.27–2.60
ER-PR- 202 _ _ 2 _ _ 1 _ _ 3 3.55 1.12–11.18
ER + PR- 125 _ _ 0 _ _ 1 _ _ 0 _ _
Ovarian 106 _ _ 2 _ _ 1 _ _ 1 _ _
Uterine 276 1.50 0.60–4.06 3 1.12 0.40–3.51 2 _ _ 1 _ _
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cases. Two previous studies reported positive associa-
tions with dieldrin use and breast cancer overall. The
first, a Danish case–control study found a significant
dose-related increased risk of breast cancer among
women and increasing serum concentrations of dieldrin
[34]. Additionally, a previous study of AHS farm spouses
found evidence for a significant increased risk of breast
cancer overall among women who never personally used
dieldrin, but whose husbands’ did personally apply the
pesticide [35]. This study was unable to assess associa-
tions between the wives’ personal use of dieldrin and
breast cancer due to the low number of dieldrin exposed
breast cancer cases. Our current analysis includes 60
more OC exposed cases and thirteen additional years of
follow-up than this previous analysis [35], and was
sufficiently powered to examine breast cancer subtypes.
Few epidemiologic studies have examined associations
between OC exposures and breast cancer subtypes
[42, 60–62], and most have not found positive associa-
tions with ER-negative breast cancers. In vitro and
animal studies have suggested that dieldrin, DDT, en-
dosulfan, HCH, and toxaphene have the potential to
elicit tumor promoting effects mediated through the
induction of ER, androgen receptor and aromatase ac-
tivities [46–48, 63, 64]. Given this body of literature
and the small number of dieldrin exposed ER-PR- breast
cancer cases, our positive finding warrants further investi-
gation. Overall we do not see strong evidence of an associ-
ation between use of an individual OC and breast cancer,
consistent with the existing epidemiologic literature.
Aldrin use was associated with a non-statistically
significant elevated risk for uterine cancer based on
four exposed cases. Only one case–control study has
examined OC exposures and endometrial cancer; no
statistically significant associations were observed with
several OC derivatives including DDE, oxychlordane,
HCH, and HCB [44]. Very few occupational studies have
examined the relationship between endometrial cancer
and exposure to other OC compounds, including poly-
chlorinated biphenyls (PCBs) [65–67] and the majority of
these studies’ findings were null. To our knowledge, this is
the first prospective study to examine the relationship be-
tween personal use of specific OC insecticides and uterine
cancer.
Any OC use and lindane specifically were associated
with risk of glioma. While we lacked sufficient power
for further subtype analyses, the OC-exposed glioma
cases consisted of glioblastomas (n = 7), an astrocytoma
(n = 1), an oligodendroma (n = 1), and mixed gliomas
(n = 2). Previous studies of male farming populations
have found some evidence for an increased risk of
glioma with associated pesticide use [68–72]. However,
studies examining associations between glioma and
pesticide exposures among women, in agricultural
populations, have provided inconsistent results. In an earl-
ier case–control study of central nervous system cancers
among women across twenty-four U.S. states, increased
risks were found for women generally exposed to herbi-
cides, insecticides, or fungicides [73]. An analysis of occu-
pational risk factors for glioma found significantly
increased risks among women involved in occupations in
agricultural services and farming, though this analysis did
not examine exposures to specific pesticides [74]. How-
ever, a case–control analysis of women in Nebraska found
no association between individually evaluated OCs (i.e. al-
drin, chlordane, DDT, dieldrin, heptachlor and lindane)
and brain cancer [68]. Similarly, in a case–control ana-
lysis of women in the Midwest, no association was
found for gliomas and the personal application of pesti-
cides including OCs [75]. Mechanisms of action for
OC-induced gliomas have not been proposed; however,
in vitro studies have found that neurotoxic effects in-
duced by the interaction of OCs with ER-mediated sig-
naling pathways may play a role [76].
The increased risk of pancreatic cancer associated with
lindane use in our study was based on only three ex-
posed cases. Some studies have shown significant in-
creased risks for pancreatic cancer with occupational
DDT exposure [26, 27] and significantly higher levels of
DDT exposure among pancreatic cancer cases versus
controls [27]. However, a previous AHS study found no
evidence for an increased risk of pancreatic cancer with
the OCs aldrin, DDT, heptachlor or toxaphene [77]. The
aforementioned study did not evaluate risk estimates
among the spouses only, but examined combined risk
estimates among the applicators and their spouses. Further-
more, a lack of exposed cases prohibited the insecticide-
specific evaluation of chlordane, dieldrin and lindane. To
our knowledge, no other studies have evaluated OC use
and pancreatic cancers among women.
Strengths of our study include the prospective longitu-
dinal design with little loss-to-follow-up, questionnaire
information on the use of specific OCs, and regular as-
sessment of cancer incidence and mortality via linkage
with state registries. The AHS also has detailed informa-
tion on many possible confounders. Most previous stud-
ies of OC exposures and cancer, except for studies of
DDT and breast cancer [7, 29–32, 36, 38, 78] have pri-
marily focused on occupationally-exposed men [79]. Our
study examined the personal use of DDT, and other spe-
cific OCs, in a population of farm women. Few studies
have evaluated personal use of specific OCs. While
breast cancer has been the most widely studied cancer
with respect to OCs, in particular DDT, no studies thus
far have prospectively studied OCs and other hormone-
mediated cancers.
Limitations of this analysis include the small number of
cases exposed to specific OCs and lack of information on
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duration, time period, and intensity of OC use. While we
had a low response rate of the female and family health
questionnaire, our reported results and final models were
based solely on information collected from the spousal en-
rollment questionnaire. Questionnaire information was
collected at study enrollment (1993–1997), thus changes in
individual characteristics (i.e. menopausal status, smoking)
since enrollment were not captured in this analysis. In
addition, most OCs examined in this analysis have been
banned for use in the United States since the 1970s. Be-
cause OCs have long half-lives, and are known to persist in
the environment and human body for long periods of time
[1–3], exposure to OCs through environmental exposure
pathways may also contribute to lifetime cumulative expos-
ure. This could be particularly important in farm situations
where OCs may have been used in the past.
Conclusions
We observed significant increased risks for some cancers
associated with individual OC insecticides. Despite the
large size of the cohort, the numbers of exposed women
and cancer cases were small for most cancer sites of
interest. While some of our findings are consistent with
previous findings, results need replication with longer
follow-up time in other studies. Due to the environmen-
tal persistence of OCs, future research should attempt to
expand on these findings by assessing environmental
sources of OC exposures in order to fully evaluate the
role of OC exposures on cancer risk in women.
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